VICTORIA ORTIZ: Open Payments
NPI 1881448082 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,204 in 136 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $833 · 2025 $4,204
Food & beverage: $3,403Travel & lodging: $681Education: $120
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 9 | $971 |
| ABBVIE INC. | 35 | $744 |
| Janssen Biotech, Inc. | 18 | $416 |
| Lilly USA, LLC | 8 | $290 |
| Madrigal Pharmaceuticals | 6 | $255 |
| Ardelyx, Inc. | 9 | $247 |
| Gilead Sciences, Inc. | 6 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $215 |
| Phathom Pharmaceuticals, Inc. | 16 | $175 |
| Novo Nordisk Inc | 2 | $145 |
Products named: INTERSTIM, TREMFYA, OMVOH, REZDIFFRA, IBSRELA, SKYRIZI, MAVYRET, RINVOQ.
Industry payments across FL — which companies pay providers there.
